Počet záznamů: 1
adjuvancia imunologická
SYS d000276 LBL 02277nz--a2200397n--4500 003 CZ-PrNML 005 20240206162307.5 008 990101-n-ancnnbaba----------||-ana-----d 035 $a (DNLM)D000276 040 $a ABA008 $b cze $f czmesh 072 $a D27. $x 505. $x 696. $x 477. $x 067 150 $a adjuvancia imunologická $2 czmesh 450 $w i $a Adjuvant, Immunologic $i UF 450 $w i $a Adjuvants, Immunological $i UF 450 $w i $a Immunoactivators $i UF 450 $w i $a Immunoadjuvant $i UF 450 $w i $a Immunoadjuvants $i UF 450 $w i $a Immunologic Adjuvant $i UF 450 $w i $a Immunologic Adjuvants $i UF 450 $w i $a Immunological Adjuvant $i UF 450 $w i $a Immunopotentiator $i UF 450 $w i $a Immunopotentiators $i UF 450 $w i $a Immunostimulant $i UF 450 $w i $a Immunostimulants $i UF 450 $w i $a imunoadjuvancia $i UF 450 $w i $a imunologické adjuvans $i UF 450 $w i $a imunostimulancia $i UF 550 $w g $a imunologické faktory $7 upol_us_auth*d007155 550 $w h $a adjuvantní vakcína $7 upol_us_auth*d000089582 550 $w i $a adjuvancia farmaceutická $i RT $7 upol_us_auth*d000277 680 $i Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. 688 $a 65 750 -2
$a Adjuvants, Immunologic $2 czmesh 980 $x M 982 $a 1
Počet záznamů: 1